Immunotherapy of Cancer: Reprogramming Tumor/Immune Cellular Crosstalk to Improve Anti-Tumor Efficacy
Immunotherapy of cancer has been shown to be promising in prolonging patient survival. However, complete elimination of cancer and life-long relapse-free survival remain to be major challenge for anti-cancer therapeutics. We have previously reported that ex vivo reprogramming of tumor-sensitized imm...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
VCU Scholars Compass
2015
|
| Subjects: | |
| Online Access: | http://scholarscompass.vcu.edu/etd/3939 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=4960&context=etd |